2017 Innovation Grants - Professor Brendan Jenkins

New therapeutic tools
Professor Brendan Jenkins Panel Image

Professor Brendan Jenkins

Grant

A Novel Translational Pipeline for the Introduction of New Immune-Based Therapies Targeting Localised and Metastatic Pancreatic Ductal Adenocarcinoma

Award

Innovation Grant 2017

Institution

Hudson Institute of Medical Research

This project aims to show the preclinical efficacy of a novel series of immune-based therapies across a range of human pancreatic tumours which have been genetically screened to predict treatment responsiveness. This project also addresses the need to identify new genes that can be the target of novel therapeutic approaches.

Professor Brendan Jenkins Image

Professor Brendan Jenkins, Hudson Institute of Medical Research

Research Reports
Click to download progress reporting on the outcomes of this research.

Progress Report

Final Report